Cleanroom design and construction are critical elements in the pharmaceutical manufacturing industry to ensure the production of safe and high-quality drugs. In the latest Expert Insights episode, industry experts Matthew Ferrin and Michael Kosinski provide valuable guidance on mastering cleanroom design and planning for future expansion.
Ensure worker safety in HPAPI cleanroom environments with Bullard’s versatile line of Powered Air Purifying Respirators (PAPRs). Designed for solid dose and clean room settings, these respirators provide effective protection against hazardous substances.
![[Podcast] Connecting Data to Improve Your Contamination Control Strategies-min](https://www.benchmarkproducts.com/wp-content/uploads/2023/09/Podcast-Connecting-Data-to-Improve-Your-Contamination-Control-Strategies-min.png)
Sheba Zaman of Novatek International is featured on the podcast to discuss how technology can provide visibility and powerful decision making for contamination control in pharmaceutical manufacturing. She explains the difficulties in the industry of digitalizing due to regulations, product safety and taking liability into account. Additionally, she discusses how utilizing data lakes and connecting elements of contamination control can provide insight and trend analysis.
Benchmark Products is excited to announce that we will be exhibiting at Interphex 2023 in New York City from April 25-27. We invite you to join us at Booth #2020 to discover our latest technologies and services that can help you become compliant with the new Annex 1 regulations.
![[Podcast] Transforming the Audit Process Innovations in Supplier Evaluations-min](https://www.benchmarkproducts.com/wp-content/uploads/2023/09/Podcast-Transforming-the-Audit-Process-Innovations-in-Supplier-Evaluations-min.png)
The Exceeding Your Benchmark podcast interviews Jim Fries, the CEO of Rx360, a non-profit that works with pharmaceutical companies and their suppliers worldwide to protect patients from pharmaceutical-related safety issues. Jim explains the Joint Audit Program which is used to assess the quality of manufacturing facilities for pharmaceutical products.
To achieve the new Annex 1 requirements, life science manufacturers need cleaning and disinfecting solutions that are backed by science and offer reliable, consistent results. In this article, we’ll explore how Suite Ultra-Fiber cleaning and disinfecting solutions can help maintain a sterile manufacturing environment.
![[Press Release] Benchmark Products Joins Rx360 to Enhance Quality and Supply Chain Security for Pharmaceutical Manufacturers-min](https://www.benchmarkproducts.com/wp-content/uploads/2023/09/Press-Release-Benchmark-Products-Joins-Rx360-to-Enhance-Quality-and-Supply-Chain-Security-for-Pharmaceutical-Manufacturers-min.png)
Benchmark Products is proud to announce its membership in Rx360, a global consortium of pharmaceutical companies, suppliers, and service providers, dedicated to advancing pharmaceutical supply chain security and quality.
The Annex 1 checklist is a helpful tool for life science manufacturers to ensure that their sterile manufacturing facilities are compliant with the latest regulations. With the new Annex 1 guidelines set to take effect in August 2023, it is more important than ever to ensure that your facility is up to date and in compliance.
Not only does mold pose a risk to patient safety, but it can also result in product recalls, financial and reputational damage, and regulatory consequences. However, by using the right preventative cleaning and disinfecting products and procedures, manufacturers can significantly reduce the risk of mold contamination in sterile environments.
![[Podcast] How Life Science Manufacturers Can Successfully Adapt to Change-min](https://www.benchmarkproducts.com/wp-content/uploads/2023/09/Podcast-How-Life-Science-Manufacturers-Can-Successfully-Adapt-to-Change-min.png)
In this episode of Exceeding Your Benchmark, Ashley Harp, Lead Process Engineer at CRB, talks about the challenges of pharmaceutical manufacturing adapting to rapid innovation of new therapies and various options to meet demand.
